Efficacy and Safety of Rilpivirine (TMC278) Versus Efavirenz at 48 Weeks in Treatment-Naive HIV-1-Infected Patients: Pooled Results From the Phase 3 Double-Blind Randomized ECHO and THRIVE TrialsCOHEN, Calvin J; MOLINA, Jean-Michel; CRAUWELS, Herta et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 1, pp 33-42, issn 1525-4135, 10 p.Article

Macrophage HIV-1 infection in duodenal tissue of patients on long term HAARTZALAR, Alberto; FIGUEROA, Maria Ines; RUIBAL-ARES, Beatriz et al.Antiviral research. 2010, Vol 87, Num 2, pp 269-271, issn 0166-3542, 3 p.Article

Antiretroviral Treatment of Adult HIV Infection : 2008 Recommendations of the International AIDS Society-USA PanelHAMMER, Scott M; ERON, Joseph J; JACOBSEN, Donna M et al.JAMA, the journal of the American Medical Association. 2008, Vol 300, Num 5, pp 555-570, issn 0098-7484, 16 p.Article

Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients : 24-week results of the RESIST-2 trialCAHN, Pedro; VILLACIAN, Jorge; MORENO, Santiago et al.Clinical infectious diseases. 2006, Vol 43, Num 10, pp 1347-1356, issn 1058-4838, 10 p.Article

Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: An international observational studyMUSSINI, Cristina; PEZZOTTI, Patrizio; BOSSI, Philippe et al.Clinical infectious diseases. 2004, Vol 38, Num 4, pp 565-571, issn 1058-4838, 7 p.Article

Higher rate of toxicity with no increased efficacy when hydroxyurea is added to a regimen of stavudine plus didanosine and nevirapine in primary HIV infectionZALA, Carlos; SALOMON, Horacio; OCHOA, Claudia et al.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 29, Num 4, pp 368-373, issn 1525-4135Article

Efficacy and Safety of Tipranavir Coadministered with Ritonavir in HIV-1-Infected Children and Adolescents: 5 Years of ExperienceSALAZAR, Juan C; CAHN, Pedro; NEGRA, Marinella Della et al.The Pediatric infectious disease journal. 2014, Vol 33, Num 4, pp 396-400, issn 0891-3668, 5 p.Article

Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteriaNOSYK, Bohdan; AUDOIN, Bertrand; STRATHDEE, Steffanie A et al.AIDS (London). 2013, Vol 27, Num 7, pp 1159-1165, issn 0269-9370, 7 p.Article

Sexual risk-taking behaviour among HIV outpatients in ArgentinaHARDING, Richard; EISENCHLAS, Jorge H; STRAUSS, Rita et al.AIDS Care (Print). 2013, Vol 25, Num 9-10, pp 1077-1082, issn 0954-0121, 6 p.Article

Antiretroviral Drugs for Preventing Mother-to-Child Transmission of HIV: A Review of Potential Effects on HIV-Exposed but Uninfected ChildrenHEIDARI, Shirin; MOFENSON, Lynne; COTTON, Mark F et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 57, Num 4, pp 290-296, issn 1525-4135, 7 p.Article

Antiretroviral Treatment of Adult HIV Infection 2010 Recommendations of the International AIDS Society-USA PanelTHOMPSON, Melanie A; ABERG, Judith A; JACOBSEN, Donna M et al.JAMA, the journal of the American Medical Association. 2010, Vol 304, Num 3, pp 321-333, issn 0098-7484, 13 p.Article

Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral loadARNAIZ, Juan A; MALLOLAS, Josep; BURGER, David M et al.AIDS (London). 2003, Vol 17, Num 6, pp 831-840, issn 0269-9370, 10 p.Article

Treatment as prevention: are Argentinean HIV care providers willing to adopt earlier antiretroviral therapy?SOCIAS, Maria Eugenia; SUED, Omar; PRYLUKA, Daniel et al.AIDS Care (Print). 2014, Vol 26, Num 11-12, pp 1446-1451, issn 0954-0121, 6 p.Article

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trialMOLINA, Jean-Michel; CAHN, Pedro; VANVEGGEL, Simon et al.Lancet (British edition). 2011, Vol 378, Num 9787, pp 238-246, issn 0140-6736, 9 p.Article

Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescentsSALAZAR, Juan C; CAHN, Pedro; MIKL, Jaromir et al.AIDS (London). 2008, Vol 22, Num 14, pp 1789-1798, issn 0269-9370, 10 p.Article

Magnitude, Breadth, and Functional Profile of T-Cell Responses during Human Immunodeficiency Virus Primary Infection with B and BF Viral VariantsTURK, Gabriela; GHERARDI, Maria Magdalena; LAUFER, Natalia et al.Journal of virology. 2008, Vol 82, Num 6, pp 2853-2866, issn 0022-538X, 14 p.Article

Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adultsCARR, Andrew; RITZHAUPT, Armin; WEI ZHANG et al.AIDS (London). 2008, Vol 22, Num 17, pp 2313-2321, issn 0269-9370, 9 p.Article

Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: Randomized trialSAAG, Michael S; CAHN, Pedro; BORROTO-ESODA, Katyna et al.JAMA, the journal of the American Medical Association. 2004, Vol 292, Num 2, pp 180-190, issn 0098-7484, 11 p.Article

Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in ArgentinaKIJAK, Gustavo H; PAMPURO, Sandra E; AVILA, Maria M et al.Antiviral therapy (London). 2001, Vol 6, Num 1, pp 71-77, issn 1359-6535Conference Paper

Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudineHAAS, David W; ARATHOON, Eduardo; BENETUCCI, Jorge et al.AIDS (London). 2000, Vol 14, Num 13, pp 1973-1978, issn 0269-9370Article

Apricitabine : a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor for the treatment of nucleoside-resistant HIV infectionWAINBERG, Mark A; CAHN, Pedro; BETHELL, Richard C et al.Antiviral chemistry & chemotherapy. 2007, Vol 18, Num 2, pp 61-70, issn 0956-3202, 10 p.Article

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trialCAHN, Pedro; ANDRADE-VILLANUEVA, Jaime; ROLON, Maria José et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 7, pp 572-580, issn 1473-3099, 9 p.Article

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING studyCAHN, Pedro; POZNIAK, Anton L; HAGINS, Debbie et al.Lancet (British edition). 2013, Vol 382, Num 9893, pp 700-708, issn 0140-6736, 9 p.Article

Cancer in HIV-Infected Persons From the Caribbean, Central and South AmericaFINK, Valeria I; SHEPHERD, Bryan E; GOTUZZO, Eduardo et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 56, Num 5, pp 467-473, issn 1525-4135, 7 p.Article

Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patientsCAHN, Pedro; FOURIE, Jan; TOMAKA, Frank et al.AIDS (London). 2011, Vol 25, Num 7, pp 929-939, issn 0269-9370, 11 p.Article